Cargando…

Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data

Botulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chien, Hsin Fen, Rosso, Ana Lucia Zuma de, Santos, André Sobierajski dos, Rieder, Carlos Roberto de Mello, Maia, Debora Palma, Silva, Delson José da, Andrade, Marcio da Cunha, Coletta, Marcus Vinicius Della, Costa, Maria do Desterro Leiros da, Allam, Nasser, Prado, Roberto César Pereira do, Borges, Vanderci, Tumas, Vitor, Horta, Wagner de Goes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803103/
https://www.ncbi.nlm.nih.gov/pubmed/29430552
http://dx.doi.org/10.1016/j.ensci.2016.07.001
_version_ 1783298628670980096
author Chien, Hsin Fen
Rosso, Ana Lucia Zuma de
Santos, André Sobierajski dos
Rieder, Carlos Roberto de Mello
Maia, Debora Palma
Silva, Delson José da
Andrade, Marcio da Cunha
Coletta, Marcus Vinicius Della
Costa, Maria do Desterro Leiros da
Allam, Nasser
Prado, Roberto César Pereira do
Borges, Vanderci
Tumas, Vitor
Horta, Wagner de Goes
author_facet Chien, Hsin Fen
Rosso, Ana Lucia Zuma de
Santos, André Sobierajski dos
Rieder, Carlos Roberto de Mello
Maia, Debora Palma
Silva, Delson José da
Andrade, Marcio da Cunha
Coletta, Marcus Vinicius Della
Costa, Maria do Desterro Leiros da
Allam, Nasser
Prado, Roberto César Pereira do
Borges, Vanderci
Tumas, Vitor
Horta, Wagner de Goes
author_sort Chien, Hsin Fen
collection PubMed
description Botulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). Analyzing the Datasus data (Unified Health System Information Department of Brazilian Ministry of Health), it was noticed that in Brazil the percentage of dystonic patient benefited from this procedure is still low. We therefore suggest some strategies to increase the dispensation of the toxin by the Brazilian Unified Health system for the dystonic patients.
format Online
Article
Text
id pubmed-5803103
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-58031032018-02-09 Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data Chien, Hsin Fen Rosso, Ana Lucia Zuma de Santos, André Sobierajski dos Rieder, Carlos Roberto de Mello Maia, Debora Palma Silva, Delson José da Andrade, Marcio da Cunha Coletta, Marcus Vinicius Della Costa, Maria do Desterro Leiros da Allam, Nasser Prado, Roberto César Pereira do Borges, Vanderci Tumas, Vitor Horta, Wagner de Goes eNeurologicalSci Original Article Botulinum toxin injections are the most effective approach for the treatment of focal dystonia. Despite growing demand and clinical indications over the years, there are few reports or publications of its use and benefit to patients seen at the Sistema Único de Saúde - SUS (Unified Health System). Analyzing the Datasus data (Unified Health System Information Department of Brazilian Ministry of Health), it was noticed that in Brazil the percentage of dystonic patient benefited from this procedure is still low. We therefore suggest some strategies to increase the dispensation of the toxin by the Brazilian Unified Health system for the dystonic patients. Elsevier 2016-07-19 /pmc/articles/PMC5803103/ /pubmed/29430552 http://dx.doi.org/10.1016/j.ensci.2016.07.001 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Chien, Hsin Fen
Rosso, Ana Lucia Zuma de
Santos, André Sobierajski dos
Rieder, Carlos Roberto de Mello
Maia, Debora Palma
Silva, Delson José da
Andrade, Marcio da Cunha
Coletta, Marcus Vinicius Della
Costa, Maria do Desterro Leiros da
Allam, Nasser
Prado, Roberto César Pereira do
Borges, Vanderci
Tumas, Vitor
Horta, Wagner de Goes
Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data
title Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data
title_full Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data
title_fullStr Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data
title_full_unstemmed Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data
title_short Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data
title_sort brief considerations on the dispensation profile of the botulinum toxin type a by the brazilian unified health system for treatment of dystonias: datasus data
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803103/
https://www.ncbi.nlm.nih.gov/pubmed/29430552
http://dx.doi.org/10.1016/j.ensci.2016.07.001
work_keys_str_mv AT chienhsinfen briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT rossoanaluciazumade briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT santosandresobierajskidos briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT riedercarlosrobertodemello briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT maiadeborapalma briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT silvadelsonjoseda briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT andrademarciodacunha briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT colettamarcusviniciusdella briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT costamariadodesterroleirosda briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT allamnasser briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT pradorobertocesarpereirado briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT borgesvanderci briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT tumasvitor briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata
AT hortawagnerdegoes briefconsiderationsonthedispensationprofileofthebotulinumtoxintypeabythebrazilianunifiedhealthsystemfortreatmentofdystoniasdatasusdata